Aurique Ltd

Aurique Other Announcement

Aurique Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with Regulation 31(1)(b).

Aurique Board Meeting Date

Aurique Limited has scheduled a board meeting for October 14, 2026, to consider and approve the unaudited standalone financial results for the quarter and half-year ended September 30, 2026.

Aurique Capital Structure Change

Aurique Ltd allotted 78,11,100 fully convertible equity warrants on a preferential basis to two allottees at an issue price of Rs. 12.00 per warrant.

Value

₹9.37 Cr

Aurique Capital Structure Change

Aurique Ltd allotted 73,50,700 fully convertible equity warrants on a preferential basis at an issue price of ₹12.00 per warrant.

Value

₹8.82 Cr

Aurique Capital Structure Change

Aurique Ltd allotted 98,38,200 warrants to two allottees at ₹12.00 per warrant, aggregating to ₹11.81 Crore.

Value

₹11.81 Cr

Aurique Annual General Meeting

Aurique Limited conducted its Extra-Ordinary General Meeting on September 03, 2026. Shareholders considered resolutions for a preferential warrant issue, object clause changes, and a director appointment.

Aurique Annual General Meeting

Aurique Limited has issued an EGM notice to seek shareholder approval for a preferential issuance of convertible warrants and alterations to its Memorandum of Association.

Aurique Annual General Meeting

Aurique Limited has issued a notice for an Extra-Ordinary General Meeting on September 3, 2026, to approve a preferential issue of 2.5 crore warrants and object clause changes.

Value

₹30.00 Cr

Aurique Capital Structure Change

Aurique Ltd approved a preferential issuance of 2.5 crore warrants at ₹12 each, aggregating ₹30 Crore. The board also reconstituted committees and appointed new auditors.

Value

₹30.00 Cr

Aurique Other Announcement

Aurique Limited has reconstituted its Audit Committee, Nomination and Remuneration Committee, and Stakeholder's Relationship Committee, effective August 03, 2026.

Aurique Board Meeting Date

Aurique Ltd scheduled a Board Meeting for August 06, 2026. The board will consider a proposal for fundraising through various equity or debt instruments.

Aurique Management Change

Ms. Bhargavi Dilipbhai Gupta has resigned as an Independent Director of Aurique Limited, effective August 1, 2026, due to personal reasons.

Aurique Board Meeting Outcome

Aurique Limited approved Q1 FY27 financial results and reclassified Nimeshkumar Patel from Promoter to Professional Director. Auditors issued a disclaimer of conclusion citing unconfirmed balances and bank trails.

Value

₹5.39 Cr

Aurique Board Meeting Date

Aurique Ltd will hold a board meeting on 15 July 2026 to approve its unaudited Q2‑2026 financial results. The notice also confirms the trading window closure.

Pae Other Announcement

Aurique Limited achieved the mandatory 25% Minimum Public Shareholding requirement, reaching 26.92%. This confirms regulatory compliance and ensures the company remains eligible for continued listing.

Pae Capital Structure Change

Aurique Limited received ROC approval for altering its Memorandum of Association's object clause. Shareholders previously approved this change during the Annual General Meeting.

Pae Bonus Issue

Aurique Limited allotted 3,00,000 bonus equity shares in a 6:1 ratio to eligible public shareholders. The issuance capitalizes ₹0.30 Crore from free reserves.

Value

₹0.30 Cr

Pae Annual General Meeting

PAEL Limited shareholders approved all five resolutions at the 76th AGM held on May 18, 2026. Approved items include financial statement adoption and dividend declaration.

Pae Annual General Meeting

Aurique Limited conducted its 76th AGM, approving financial statements, dividends, and director re-appointments. Shareholders also considered bonus share issuance and object clause alterations.

Pae Other Announcement

Aurique Limited filed its Annual Secretarial Compliance Report for FY2025-26. The auditor confirmed general compliance with SEBI regulations, noting previous delays were regularized by BSE.